Tirzepatide Weight Loss Results: How Zepbound & Mounjaro Work (2026)

Tirzepatide descriTirzepatide (Zepbound for weight loss / Mounjaro for type 2 diabetes) is delivering some of the strongest clinical weight-loss results among current GLP-1/GIP dual agonists. In this video we break down exactly how tirzepatide works, average weight-loss percentages from the SURMOUNT trials, real-world results people are seeing, common side effects, dosage titration, and how it compares to semaglutide (Ozempic/Wegovy).
What you’ll learn:
• How the dual GIP + GLP-1 action reduces appetite and improves blood sugar
• Typical weight loss at 5 mg, 10 mg, and 15 mg doses
• What to expect in the first 4–12 weeks
• Managing nausea, fatigue, and other side effects
• Cost, insurance, and access tips in 2026
• Who is a good candidate (and who should avoid it)
Always consult your doctor before starting or changing any medication. This is educational content only — not medical advice.
If this helped, like, subscribe, and drop your questions or results in the comments.
#Tirzepatide #Zepbound #Mounjaro #WeightLoss #GLP1 #TirzepatideWeightLossption